Glioblastoma and Brain Tumour Therapy
Clinical research in glioblastoma focuses on patients with newly diagnosed supratentorial, IDH wild-type disease, with interest in treatment approaches for central nervous system malignancies and local tumour-directed intervention.
- Glioblastoma
- Supratentorial brain tumours
- IDH wild-type glioma
- Photodynamic therapy
The therapeutic emphasis includes interstitial photodynamic therapy in neuro-oncology, reflecting an interest in precision-localized treatment for aggressive brain tumours.
Colorectal Carcinoma and Gastrointestinal Oncology
Research activity also includes colorectal carcinoma, with attention to patients experiencing a first diagnosis of colorectal cancer and to related clinical evaluation in the gastrointestinal cancer setting.
- Colorectal carcinoma
- Colorectal cancer
- Gastrointestinal oncology
- Oral therapeutic administration
The sponsor’s interests extend to cancer care pathways where diagnostic and therapeutic evaluation intersect in early-stage CRC.
Porphyrin Biomarkers and Urinary Diagnostics
Another area of interest is the assessment of porphyrin concentration in urine, including coproporphyrin I and coproporphyrin III, for use in clinical characterization of cancer-related biological changes.
- Porphyrin biomarkers
- Coproporphyrin I/III
- Urinary biomarker analysis
- Diagnostic oncology
This work connects metabolic marker profiling with cancer assessment in both patients and healthy subjects.
Neuro-Oncology and Oncologic Device-Drug Concepts
The sponsor’s portfolio shows involvement in neuro-oncology and treatment concepts that combine pharmaceutical and procedure-based elements, especially in tumour-directed approaches for brain cancer.
- Neuro-oncology
- Brain cancer
- Interventional oncology
- Theranostic concepts
These interests are reflected in studies evaluating local treatment strategies alongside clinically relevant biomarker assessment.
